Anti-NMDAR @entity75 is included in @entity75 and show the good response to treatment compared to other @entity8231 . Treatment of anti-NMDAR @entity75 includes immunotherapy and/or @entity5 removal. About 65% of patients with anti-NMDAR @entity75 had fully or near-full recovery. Immunotherapy is principally necessary and effective in @entity1 with and without @entity5 . Corticosteroids and intravenous immunoglobulin are most frequently used. It is likely that @entity1 who do not respond to one form of immunotherapy might respond to others regimens including plasmapheresis, @entity786 , and rituximab. A @entity5 was found in 58% of patients with anti-NMDAR @entity75 . Early @entity5 should be considered based on following reasons. First, @entity1 with @entity43 showed higher mortality and higher titer of anti-NMDAR antibody compared with those without. Second, relapsing @entity16 occurred in 13% of @entity1 , usually related to a delay in @entity5 diagnosis. Third, when a @entity5 was found and removed, recovery was faster and predictable. However, early @entity5 cannot be conducted because of unstable conditions such as @entity3316 and @entity910 . In supportive cares, severe @entity11627 requires mechanical ventilation. The @entity2358 and facial @entity910 are refractory to anti- @entity302 drugs. In conclusion, search for and removal of an @entity43 should be promptly considered after the diagnosis of anti-NMDAR @entity75 .

[Anti-NMDAR XXXX : treatment].

@entity1 :: ('9606', 'Species') :: ['patients'] @entity43 :: ('MESH:D010051', 'Disease') :: ['ovarian teratoma'] @entity11627 :: ('MESH:C536209', 'Disease') :: ['central hypoventilation'] @entity75 :: ('MESH:D001927', 'Disease') :: ['paraneoplastic limbic encephalopathy', 'encephalopathy'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor', 'removal of tumor'] @entity16 :: ('MESH:D009422', 'Disease') :: ['neurological symptoms'] @entity2358 :: ('MESH:D020820', 'Disease') :: ['involuntary movements'] @entity786 :: ('MESH:D003520', 'Chemical') :: ['cyclophosphamide'] @entity910 :: ('MESH:D004409', 'Disease') :: ['dyskinesias'] @entity302 :: ('MESH:D004827', 'Disease') :: ['epileptic'] @entity3316 :: ('MESH:D007040', 'Disease') :: ['hypoventilation'] @entity8231 :: ('MESH:D010257', 'Disease') :: ['paraneoplastic syndromes']
@entity75 :: (MESH:D001927,Disease) :: ['encephalopathy']
